Aarti Pharma (AARTIPHARM)

STALWART

FairStock Score: 8/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹688.15
Market Cap₹6,560.14 Cr
P/E Ratio30.39
ROCE17.44%
ROE12.59%
Dividend Yield0.69%
Profit Growth-32.3%
Debt/Equity0.33
Sales Growth-19.62%
Promoter Holding43.1%
52-Week Range₹585 — ₹971
SectorPharmaceuticals & Biotechnology
Book Value₹187.86

Aarti Pharma trades with a P/E ratio of 30.39, ROCE of 17.44%, ROE of 12.59%, profit growth of -32.3%, debt-to-equity of 0.33. The FairStock Score of 8/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer